Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S B Margolin

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
International Immunopharmacology|April 5, 2008
Effects of three anti-TNF-alpha drugs: etanercept, infliximab and pirfenidone on release of TNF-alpha in medium and TNF-alpha associated with the cell in vitroK J Grattendick, J M Nakashima, L Feng, et al.
The Journal of Laboratory and Clinical Medicine|December 16, 1998
Involution of keloid implants in athymic mice treated with pirfenidone or with triamcinoloneM R Shetlar, D J Shetlar, R F Bloom, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|March 27, 2002
Pirfenidone inhibits early myointimal proliferation but has no effect on late lesion size in ratsJ R Waller, G J Murphy, G R Bicknell, et al.
The Journal of Laboratory and Clinical Medicine|June 1, 1995
Dietary intake of pirfenidone ameliorates bleomycin-induced lung fibrosis in hamstersS N Iyer, J S Wild, M J Schiedt, et al.
Clinical and Experimental Immunology|August 11, 1998
Pirfenidone induces intercellular adhesion molecule-1 (ICAM-1) down-regulation on cultured human synovial fibroblastsM Kaneko, H Inoue, R Nakazawa, et al.
Journal of Nephrology|January 11, 2002
Pirfenidone reduces in vitro rat renal fibroblast activation and mitogenesisT D Hewitson, K J Kelynack, M G Tait, et al.
European Journal of Clinical Pharmacology|January 1, 1997
Pharmacokinetics of an antifibrotic agent, pirfenidone, in haemodialysis patientsM Taniyama, S Ohbayashi, M Narita, et al.
Transplantation Proceedings|December 26, 2001
Effects of pirfenidone on vascular smooth muscle cell proliferation and intimal hyperplasia following arterial balloon injuryJ R Waller, G J Murphy, M S Metcalfe, et al.
Journal of Korean Medical Science|August 19, 2003
Pirfenidone suppressed the development of glomerulosclerosis in the FGS/Kist mouseHo-Sun Park, Lihua Bao, Yong-Jin Kim, et al.
Kidney International. Supplement|January 4, 1998
Pirfenidone prevents collagen accumulation in the remnant kidney in rats with partial nephrectomyT Shimizu, M Fukagawa, T Kuroda, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
International Immunopharmacology|April 5, 2008
Effects of three anti-TNF-alpha drugs: etanercept, infliximab and pirfenidone on release of TNF-alpha in medium and TNF-alpha associated with the cell in vitroK J Grattendick, J M Nakashima, L Feng, et al.
The Journal of Laboratory and Clinical Medicine|December 16, 1998
Involution of keloid implants in athymic mice treated with pirfenidone or with triamcinoloneM R Shetlar, D J Shetlar, R F Bloom, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|March 27, 2002
Pirfenidone inhibits early myointimal proliferation but has no effect on late lesion size in ratsJ R Waller, G J Murphy, G R Bicknell, et al.
The Journal of Laboratory and Clinical Medicine|June 1, 1995
Dietary intake of pirfenidone ameliorates bleomycin-induced lung fibrosis in hamstersS N Iyer, J S Wild, M J Schiedt, et al.
Clinical and Experimental Immunology|August 11, 1998
Pirfenidone induces intercellular adhesion molecule-1 (ICAM-1) down-regulation on cultured human synovial fibroblastsM Kaneko, H Inoue, R Nakazawa, et al.
Journal of Nephrology|January 11, 2002
Pirfenidone reduces in vitro rat renal fibroblast activation and mitogenesisT D Hewitson, K J Kelynack, M G Tait, et al.
European Journal of Clinical Pharmacology|January 1, 1997
Pharmacokinetics of an antifibrotic agent, pirfenidone, in haemodialysis patientsM Taniyama, S Ohbayashi, M Narita, et al.
Transplantation Proceedings|December 26, 2001
Effects of pirfenidone on vascular smooth muscle cell proliferation and intimal hyperplasia following arterial balloon injuryJ R Waller, G J Murphy, M S Metcalfe, et al.
Journal of Korean Medical Science|August 19, 2003
Pirfenidone suppressed the development of glomerulosclerosis in the FGS/Kist mouseHo-Sun Park, Lihua Bao, Yong-Jin Kim, et al.
Kidney International. Supplement|January 4, 1998
Pirfenidone prevents collagen accumulation in the remnant kidney in rats with partial nephrectomyT Shimizu, M Fukagawa, T Kuroda, et al.
Pageof 2